Articles related to GENETIC TESTING/MUTATIONS
Investigators Devise Novel Test to Identify Brain Tumors from Cerebrospinal Fluid
The newly developed Real-CSF test offers a significant leap in diagnosing brain tumors, accurately identifying cancerous lesions in 67% of cases by analyzing cerebrospinal fluid for abnormal genetic material.
Neurology February 6th 2024
Case 2-2024: A 57-Year-Old Woman with Melanoma and Fever
A look into the complexities of managing advanced melanoma with BRAF–MEK inhibitors, highlighting a case study where treatment-induced toxic effects posed significant diagnostic and therapeutic challenges.
Hematology/Oncology January 22nd 2024
Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer
This study highlights repotrectinib’s remarkable efficacy in ROS1 fusion–positive NSCLC, demonstrating a notable response even in patients with the challenging ROS1 G2032R mutation, and presents a new potential standard in targeted lung cancer therapy.
Oncology, Medical January 16th 2024
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated KRAS G12C
The recent phase 3 trial has demonstrated that the combination of the KRAS G12C inhibitor, sotorasib, with the EGFR inhibitor, panitumumab, can lead to longer progression-free survival in patients with chemorefractory metastatic colorectal cancer.
Oncology, Medical January 2nd 2024
A Guide to Genetic Testing in Pediatric Epilepsy
With an estimated 30% to 40% of unexplained epilepsy cases having a genetic etiology, the newest tools offer the potential for timely, accurate diagnoses, resulting in personalized care that can improve outcomes and enhance quality of life.
Neurology November 14th 2023